Karyopharm Therapeutics Inc. earnings per share and revenue

KPTI earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.30 USD which accounts for 32.85% surprise. Company revenue for the same period amounts to 42.79 M USD despite the estimated figure of 36.21 M USD. Estimated earnings per share for the next quarter are -0.26 USD, and revenue is expected to reach 37.92 M USD. Also watch annual changes over time to get a bigger picture of KPTI earnings per share and revenue dynamics.